WHO approved Tocilizumab ( Temziva )as covid-19 treatment

Aming to increase access to recommended treatments for Covid-19, The World Health Organization (WHO) has added Tocilizumab in three doses to it’s list of approved treatments for Covid-19. AryoGen Pharmed is the only company producing Biosimilar form of the drug with the commercial name of Temziva in the world since the beginning of the Corona pandemic.

More» 

https://www.who.int/news/item/11-02-2022-who-prequalifies-first-monoclonal-antibody—tocilizumab-to-treat-covid-19